Newsletters

  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
All
  • All
  • Incentives
  • Jobs
  • Media & Graphics
  • PK & PK-PD
  • R&D Insight
  • Wonkish
  • Y2017
  • Y2018
  • Y2019
  • Y2020
R&D InsightY2020

Let’s help Alan Carr do a COVID-19 point insight survey

Dear All, I promise that the next email will be all about the 25 Mar 2020 NHS England webinar on …

Read More >
IncentivesY2020

Send a note to your congressman/woman today!

Dear All, If you are a US citizen, you have an opportunity right now (as in today/tomorrow) to push for …

Read More >
IncentivesR&D Insight

Tetraphase sold for $14m … and $600m goes up in smoke!

Dear All (and with thanks to Kevin Outterson for co-authoring this newsletter): Wonkish and long note alert … top-up your coffee …

Read More >
IncentivesY2020

Sweden to test an access-focused model for new antibiotics: Contracting for Availability

Dear All: Sweden has been a steady supporter of work on incentives for antibiotics for over a decade – as …

Read More >
IncentivesY2020

NHS England antibiotic procurement pilot project: Update webinar on 25 Mar 2020

Dear All, This email was just today received from the team leading the NHS England antibiotic procurement project (go here …

Read More >
JobsY2020

WHO R&D-focused consultancy: Data coordinator for next WHO pipeline review

Dear All, As you know, WHO has been driving a series of clinical and preclinical pipeline reviews (go here for …

Read More >
PK & PK-PDR&D Insight

FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)

Dear All (detailed and wonkish note alert … lots of thinking out loud … get some coffee and settle in!), …

Read More >
R&D InsightWonkish

What does an antibiotic cost to develop? What is it worth? How to afford it?

Dear All (long, wonkish note alert!): Today we have a 3-part discussion of cost and value with this summary 3-part …

Read More >
R&D InsightY2020

Glaxo seeks buyer for two of its older antibiotics / AMR podcasts to share

Heads-up … numerous changes in the meeting calendar: Lots of new events as well as rescheduling of previously announced events. …

Read More >
JobsY2020

Consultancy at WHO: manage a fund for implementation of AMR-focused actions / 17 Mar 2020 deadline

Dear All, A fascinating job posting has gone up from WHO and the full text is just below my signature. …

Read More >
R&D InsightY2020

Chemicals vs. drugs (Part 3): XKCD has the final word

Dear All, As a coda to the two newsletters on Chemicals, Drugs, and Halicin (link and link), XKCD gets the …

Read More >
JobsY2020

WHO consultancy to support AMR-related messaging / 2 Mar 2020 deadline!

Dear All, WHO has just posted a job opening for a consultant in Geneva to help with spreading the word …

Read More >
R&D InsightWonkish

Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin

Dear All (wonkish note alert!), The recent newsletter on chemicals, drugs, and halicin (link, see also a follow-up newsletter here) …

Read More >
R&D InsightY2020

Chemicals vs. drugs (Part 1): The end of bacitracin / the buzz around halicin

This newsletter has a follow-up here. Dear All, Today’s theme is a 2-part journey that could be subtitled “Many are …

Read More >
PK & PK-PDR&D Insight

Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR

Note: See also these related newsletters: 13 Jan 2019 (link) on DTR as part of the language of resistance and …

Read More >
R&D InsightWonkish

Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?

Dear All (wonk-ish note alert and also with particular thanks as always to Kevin Outterson for helping to refine this …

Read More >
PK & PK-PDR&D Insight

FDA workshop: Animal models to support antibacterial development (5 Mar 2020)

Dear All (moderately long note alert; be sure to note the new list of funding opportunities just below my signature), …

Read More >
JobsY2020

Jobs x 2: Singapore (Clinical Research Network Director) and WHO (home-based consultant)

Dear All, Two fascinating job opportunities have appeared. Even if you’re not looking for a job, the job descriptions tell …

Read More >
R&D InsightY2020

Mandatory reading: Alan Carr’s Jan 2020 Antibacterial and Antifungal market review

Dear All, Alan Carr has just released his Jan 2020 review of the antibacterial and antifungal market (link). For those …

Read More >
IncentivesWonkish

News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point

Dear All (and heads-up for a rather lengthy and wonkish note … settle in for the details), Last week saw …

Read More >
Scroll to Top